Development and Validation of a Multimodal AI-Based Model for Predicting Post-Prostatectomy Treatment Outcomes from Baseline Biparametric Prostate MRI

Read full text Summarise with VIRAT
Authors: Benjamin Simon, Esra Akçiçek, Stephanie A. Harmon, Lei Clifton, Anshul Thakur, Sandeep Gurram, DA Clifton, Bradford J. Wood, Ali Devrim Karaosmanoğlu, Peter L. Choyke, Deniz Akata, Peter A Pinto
+1 more Barış Türkbey
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Prostate cancer (PCa) is the second most common cancer and cause of cancer death in American men. Existing risk prediction methods have limited accuracy and reproducibility, resulting in difficulty in predicting disease severity. We demonstrate the development and external validation of an automated multimodal artificial intelligence algorithm using biparametric MRI (bpMRI) and clinical covariates for predicting biochemical recurrence (BCR) after radical prostatectomy (RP) in PCa patients. Development cohort included 80% of patients from center 1 ( n = 240) who underwent prostate MRI prior to RP between January 2008 and December 2018 with a minimum of two years of follow-up after RP. Test cohort included the remaining 20% of center 1 patients ( n = 71), and the external validation cohort from center 2 ( n = 168). Center 2 patients included those who underwent prostate MRI and RP between January 2015 and December 2024 with a minimum of two years of follow-up. Clinical comparisons were CAPRA-S (center 1) and ISUP grade group from post-RP biopsy (center 2). Models developed were a clinical model (M0), an automated clinical model (M1), a radiomics model (M2), and a multimodal model (M3). Clinical variables (M0) included PSA, age, primary Gleason, and ISUP grade group. Automated clinical variables (M1 and M3) included PSA and age. Radiomics features (M2 and M3) were extracted from bpMRI using a lesion detection algorithm. Accuracy, sensitivity, specificity, and AUC were calculated, and log-rank tests compared BCR-free survival to assess the models’ ability to discriminate relative to clinical standards. Intermediate-risk groups were also assessed. The multimodal model (M3) had the highest AUC across test sets (combined: 0.71; center 1: 0.70; center 2: 0.75) and was the only model to significantly differentiate BCR-free survival outcomes in intermediate-risk groups across both centers ( p < 0.05). This automated multimodal model leveraging radiomics and clinical covariates can predict BCR after RP, approaches clinical gold standards, and may enhance imaging-based prognostication following further validation.

Fields of Study & Subjects

Radiomics and Machine Learning in Medical Imaging Prostate Cancer Diagnosis and Treatment Artificial Intelligence in Healthcare and Education

Publication details

Journal / source
medRxiv
Publication date
22 March 2026
Language
EN
Document type
Preprint